Acute Pericarditis

1. Executive Overview: Understanding Acute Pericarditis

Acute pericarditis is a clinical syndrome characterized by inflammation of the pericardium, the double-layered fibroelastic sac that encloses the heart. In clinical practice, it is defined by the presence of at least two of the four diagnostic criteria: typical chest pain, pericardial friction rub, suggestive electrocardiographic (ECG) changes, and new or worsening pericardial effusion.

Classified under ICD-10 code I30.9 (Acute pericarditis, unspecified), this condition is the most common disorder of the pericardium encountered in emergency departments and cardiology clinics. While often idiopathic or viral in origin, the clinical management requires a meticulous approach to rule out life-threatening differentials such as myocardial infarction, aortic dissection, or pulmonary embolism. Recognizing the inflammatory nature of the disease is paramount, as failure to manage the acute phase effectively can lead to complications such as pericardial tamponade or the development of chronic constrictive pericarditis.

2. Pathophysiology, Etiology, and Risk Factors

The Pathophysiological Mechanism

The pericardium consists of an outer fibrous layer and an inner serous layer (parietal and visceral). Acute inflammation triggers an influx of inflammatory cells (neutrophils and macrophages) and the release of cytokines (IL-1, IL-6, TNF-alpha). This response leads to increased vascular permeability, fibrin deposition, and the accumulation of pericardial fluid. If the inflammatory process persists, it may result in pericardial thickening or adhesions, potentially restricting ventricular filling.

Etiology and Classification

The etiology of acute pericarditis is diverse, typically categorized into infectious and non-infectious causes:

Risk Factors

• Recent Viral Illness: Upper respiratory or gastrointestinal infections.
• Immunocompromised Status: HIV/AIDS or chemotherapy.
• History of Cardiac Surgery: Particularly procedures involving pericardial opening.
• Renal Failure: Specifically patients on long-term dialysis.

3. Signs, Symptoms, and Clinical Presentation

The clinical presentation is often distinct, allowing for a high index of suspicion upon patient interview.

• Chest Pain: The hallmark symptom. It is typically retrosternal, sharp, and pleuritic (worsening with deep inspiration or coughing). A classic feature is improvement when sitting up and leaning forward (the "tripod" position).
• Pericardial Friction Rub: The pathognomonic sign. A superficial, scratchy, or squeaky sound heard best at the left sternal border with the patient leaning forward. It is often transient and varies with the respiratory cycle.
• Systemic Symptoms: Fever, malaise, and tachycardia are common, reflecting the systemic inflammatory response.
• Dyspnea: May occur due to splinting of respirations to avoid pain or, in severe cases, due to pericardial effusion causing cardiac compression.

4. Standard Diagnostic Evaluation & Workup

Diagnostic evaluation follows a structured path to ensure the exclusion of mimics and to identify the underlying etiology.

Diagnostic Criteria (Must meet 2 of 4)

1. Chest Pain: Characteristic sharp, pleuritic, positional pain.
2. Pericardial Friction Rub: Auscultatory finding.
3. ECG Changes: New widespread ST-segment elevation or PR-segment depression.
4. Pericardial Effusion: New or worsening fluid accumulation detected via echocardiography.

Laboratory Assays

• Inflammatory Markers: CRP and ESR are typically elevated and are essential for monitoring treatment response.
• Cardiac Biomarkers: Troponin and CK-MB levels are often elevated in myopericarditis (involvement of the myocardium).
• Routine Labs: CBC (to check for leukocytosis), BUN/Creatinine (to rule out uremic pericarditis).

Imaging Modalities

• Electrocardiogram (ECG): Stages of ECG changes:
  • Stage I: Widespread ST elevation with PR depression.
  • Stage II: Normalization of ST and PR segments.
  • Stage III: Diffuse T-wave inversions.
  • Stage IV: Return to baseline.
• Echocardiography: The gold standard for detecting pericardial effusion and assessing for signs of tamponade (diastolic collapse of cardiac chambers).
• Cardiac MRI/CT: Indicated when echocardiography is inconclusive or when there is suspicion of pericardial thickening or masses.

5. Therapeutic Interventions

Pharmacotherapy

The standard of care centers on controlling inflammation and preventing recurrence.

1. First-Line Therapy:
2. NSAIDs: Ibuprofen (600–800 mg every 8 hours) or Aspirin are the cornerstones of therapy, typically continued for 1–2 weeks with a gradual taper.
3. Colchicine: Recommended as an adjunct to NSAIDs for all patients with acute pericarditis to decrease the risk of recurrence. Dose is weight-based (0.5 mg once or twice daily).
4. Second-Line Therapy:
5. Corticosteroids: Reserved for patients with contraindications to NSAIDs or refractory cases. Must be used with caution as they are associated with a higher risk of recurrent pericarditis.
6. Refractory/Recurrent Cases:
7. IL-1 receptor antagonists (e.g., Anakinra) may be considered in specialized centers for recurrent, steroid-dependent disease.

Surgical/Invasive Interventions

• Pericardiocentesis: Indicated only for cardiac tamponade or if a purulent/neoplastic etiology is suspected.
• Pericardial Window: Considered for recurrent effusions or chronic constrictive pericarditis.

Lifestyle Modifications

• Physical Activity: Restriction of competitive sports and intense exercise is recommended until symptoms resolve and inflammatory markers (CRP) normalize.

6. Massive FAQ Section

1. Is acute pericarditis a heart attack?
No. While the chest pain can mimic a heart attack, pericarditis is inflammation of the sac surrounding the heart, whereas a heart attack is damage to the heart muscle itself due to lack of blood flow.

2. How long does acute pericarditis last?
Most uncomplicated cases resolve within 2 to 6 weeks with proper anti-inflammatory treatment.

3. What is the biggest complication of acute pericarditis?
The most severe acute complication is cardiac tamponade, where fluid buildup compresses the heart. Long-term, the risk is constrictive pericarditis, where the sac becomes scarred and rigid.

4. Can I exercise with acute pericarditis?
No. Patients should avoid strenuous physical exertion until they are asymptomatic and inflammatory markers have normalized, typically for at least 3 months for competitive athletes.

5. Why is Colchicine prescribed?
Colchicine is highly effective at preventing recurrent episodes of pericarditis and helps the primary anti-inflammatory medication work more effectively.

6. Is pericarditis hereditary?
Most cases are not. However, some underlying autoimmune conditions that trigger pericarditis may have a genetic component.

7. Can a virus cause pericarditis?
Yes, viral infections are the most common cause of acute pericarditis, particularly in healthy, younger adults.

8. Will my ECG return to normal?
Yes, in most cases, the ECG changes associated with acute pericarditis resolve as the inflammation subsides.

9. When should I seek emergency care?
If you experience sudden, severe shortness of breath, lightheadedness, syncope (fainting), or a rapid/irregular heartbeat, you should seek emergency medical attention immediately.

10. Can I prevent recurrence?
Adherence to the prescribed colchicine regimen is the single most effective way to prevent the recurrence of pericarditis.

Disclaimer: This guide is for educational purposes and does not constitute formal medical advice. Always consult with a board-certified cardiologist for diagnosis and treatment plans tailored to your specific clinical needs.

Related Clinical Integration

In the management of acute pericarditis, a systematic clinical approach is essential to confirm the diagnosis, mitigate inflammation, and monitor for potential complications. Initial diagnostic evaluation typically begins with an Electrocardiogram (ECG) / تخطيط القلب الكهربائي (ECG) (خدمات رعاية عامة) to identify characteristic ST-segment changes, while Ambulatory ECG Monitoring (Holter) - Extended / مراقبة تخطيط القلب الكهربائي المتنقلة (هولتر) - ممتدة (فحص بالمنظار أو أخذ عينات) may be utilized to assess for associated arrhythmias. Pharmacological intervention focuses on symptom relief and the prevention of recurrence, primarily through the administration of Advil / أدفيل 200mg as a first-line non-steroidal anti-inflammatory drug, often in combination with Colchicine / كولشيسين 0.5mg to improve therapeutic outcomes. In cases where patients present with signs of cardiac tamponade or significant effusion, urgent intervention via Pericardiocentesis / بزل التامور (خدمات رعاية عامة) is indicated to relieve hemodynamic compromise and provide diagnostic fluid analysis.